1-3 of 3
Roberto Dina
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Alterations of Choline Phospholipid Metabolism in Endometrial Cancer Are Caused by Choline Kinase Alpha Overexpression and a Hyperactivated Deacylation Pathway

Sebastian Trousil, Patrizia Lee, David J. Pinato, James K. Ellis, Roberto Dina, Eric O. Aboagye, Hector C. Keun, Rohini Sharma
Journal: Cancer Research
Cancer Res (2014) 74 (23): 6867–6877.
https://doi.org/10.1158/0008-5472.CAN-13-2409
Published: 30 November 2014
View article titled, Alterations of Choline Phospholipid Metabolism in Endometrial Cancer Are Caused by Choline Kinase Alpha Overexpression and a Hyperactivated Deacylation Pathway
Open the PDF for Alterations of Choline Phospholipid Metabolism in Endometrial Cancer Are Caused by Choline Kinase Alpha Overexpression and a Hyperactivated Deacylation Pathway in another window
Includes: Supplementary data
Journal Articles

HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer

Euan A. Stronach, Albandri Alfraidi, Nona Rama, Christoph Datler, James B. Studd, Roshan Agarwal, Tankut G. Guney, Charlie Gourley, Bryan T. Hennessy, Gordon B. Mills, Antonello Mai, Robert Brown, Roberto Dina, Hani Gabra
Journal: Cancer Research
Cancer Res (2011) 71 (13): 4412–4422.
https://doi.org/10.1158/0008-5472.CAN-10-4111
Published: 30 June 2011
View article titled, HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer
Open the PDF for HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract #LB-108: The OPCML tumor suppressor negatively regulates expression and activity of HER2 and EGFR, and may predict ovarian and breast cancer response to Lapatinib

Arthur McKie, Imoh Okon, Sebastian Vaughan, Dmitry Shaposhnikov, Joshua Wong, Justin Stebbing, Roshan Agarwal, Roberto Dina, Mona El-Bahrawy, Eric Lam, Hani Gabra
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): LB-108.
Published: 01 May 2009
View article titled, Abstract #LB-108: The OPCML tumor suppressor negatively regulates expression and activity of HER2 and EGFR, and may predict ovarian and breast cancer response to Lapatinib